Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2014
11/27/2014US20140350251 Herbicidal pyrimidines
11/27/2014US20140350242 Pseudorotaxanes, rotaxanes and catenanes formed by metal ions templating
11/27/2014US20140350056 Trpv1 antagonists including dihydroxy substituent and uses thereof
11/27/2014US20140350055 Novel soft rock inhibitors
11/27/2014US20140350034 Aminopyridine derivatives as plasma kallikrein inhibitors
11/27/2014US20140349999 Methods for treating antipsychotic-induced weight gain
11/27/2014US20140349996 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
11/27/2014US20140349992 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/27/2014US20140349991 Chromone derivative having osteogenesis promoting effect
11/27/2014US20140349987 PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORy, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES
11/27/2014US20140349986 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
11/27/2014US20140349973 Metalloenzyme inhibitor compounds
11/27/2014US20140349918 Derivatives of xanthone compounds
11/27/2014US20140348950 Pyrrolidine- substituted flavone derivatives for prevention or treatment of oral mucositis
11/25/2014US8895761 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2-phenylcyclohexane-1,3,5-triones as herbicides
11/25/2014US8895749 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
11/25/2014US8895688 Halogen-free flame retarding materials based on bisphenol triazole resins and polymers
11/25/2014US8895601 Pyrazolyl quinoxaline kinase inhibitors
11/25/2014US8895596 Cyclic benzimidazole derivatives useful as anti-diabetic agents
11/25/2014US8895589 Pyridinyl amides as P2X3 and P2X2/3 inhibitors
11/25/2014US8895587 Insecticidal compounds based on arylthioacetamide derivatives
11/25/2014US8895565 Heterocyclic compound and use of the same
11/25/2014US8895559 Quinoxalines derivatives and pharmaceutical compositions and kits
11/25/2014US8895558 Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
11/25/2014US8895554 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
11/25/2014US8895551 Acrylamide compounds and the use thereof
11/25/2014US8895548 Pharmaceutical composition for treating alzheimer's disease
11/25/2014US8895545 Acrylamide derivatives as Fab I inhibitors
11/25/2014US8895535 Pyrrolidinones as MetAP-2 inhibitors
11/25/2014US8895159 Aromatic amine derivative and organic electroluminescence device using the same
11/25/2014US8895035 Alkoxyimino derivative and pest control agent
11/20/2014US20140343292 Process for the preparation of a thioprecursor for statins
11/20/2014US20140343285 Process for the Preparation of Triazole Antifungal Drug, Its Intermediates and Polymorphs Thereof
11/20/2014US20140343283 Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof
11/20/2014US20140343279 Process for the preparation of histamine h3 receptor modulators
11/20/2014US20140343278 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
11/20/2014US20140343277 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
11/20/2014US20140343091 Beta2-adrenoceptor agonists
11/20/2014US20140343086 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
11/20/2014US20140343078 Compositions and methods for inhibiting cytochrome p450 2d6
11/20/2014US20140343077 Hepatitis c inhibitor compounds
11/20/2014US20140343074 Oxindole Derivatives Carrying An Oxetane Substituent and use thereof for Treating Vasopressine-Related Diseases
11/20/2014US20140343070 Proton pump inhibitors
11/20/2014US20140343065 New Somatostatin receptor subtype 4 (SSTR4) agonists
11/20/2014US20140343061 1,3,5 -Triazine-2-Amine Derivatives, Preparation Thereof And Diagnostic And Therapeutic Use Thereof
11/20/2014US20140343059 Novel piperazines, pharmaceutical compositions and methods of use thereof
11/20/2014US20140343052 Phenylxanthene Derivatives
11/20/2014US20140343049 Dihydrofuran derivatives as insecticidal compounds
11/20/2014US20140343045 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof
11/20/2014US20140343042 Nicotine receptor targeted compounds and compositions
11/20/2014US20140343038 1,2,4-triazine-6-carboxamide derivative
11/20/2014US20140343037 Benzene, pyridine, and pyridazine derivatives
11/20/2014US20140343031 N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents
11/20/2014US20140343006 HIV Replication Inhibiting Pyrimidines
11/20/2014US20140341986 Biguanide Compositions and Methods of Treating Metabolic Disorders
11/20/2014US20140341851 Novel benzimidazole derivatives
11/20/2014US20140341850 Haloalkyl heteroaryl benzamide compounds
11/18/2014US8889878 Haloalky-substituted amides as insecticides and acaricides
11/18/2014US8889875 Pyridyl derivatives as CFTR modulators
11/18/2014US8889874 Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof
11/18/2014US8889730 Indole and indazole compounds that activate AMPK
11/18/2014US8889726 Chemica compounds
11/18/2014US8889716 Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/18/2014US8889709 Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
11/18/2014US8889708 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
11/18/2014US8889700 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
11/18/2014US8889694 N-alkoxyamides of 6-(substituted phenyl)-4-aminopicolinates and 2-(substituted phenyl)-6-amino-4-pyrimidinecarboxylates and their use as selective herbicides for crops
11/18/2014US8889690 TRPV1 antagonists including dihydroxy substituent and uses thereof
11/18/2014US8889677 Substituted triazoles useful as mGlu5 receptor modulators
11/18/2014US8889674 Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism
11/18/2014US8889670 Heterocyclic compounds which modulate the CB2 receptor
11/13/2014US20140336389 Method for manufacturing 4-benzyl-1-methyl-6-oxabicyclo[3,2,0]heptane derivative and method for manufacturing azole derivative
11/13/2014US20140336387 Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof
11/13/2014US20140336376 Pharmaceutical composition for treating diabetes
11/13/2014US20140336375 Allosteric modulators of 5-hydroxytryptamine 2c receptor (5-ht2cr)
11/13/2014US20140336374 Process and intermediates for the production of ccr2 antagonists
11/13/2014US20140336232 2-iodo imidazole-derivatives
11/13/2014US20140336209 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
11/13/2014US20140336208 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
11/13/2014US20140336200 Arylosulfonamides for the treatment of cns diseases
11/13/2014US20140336198 Amine Derivatives as Potassium Channel Blockers
11/13/2014US20140336193 Potent non-urea inhibitors of soluble epoxide hydrolase
11/13/2014US20140336192 3-phenyl-isoquinolin-1(2h)-one derivatives as parp-1 inhibitors
11/13/2014US20140336191 Quinolinyloxyphenylsulfonamides
11/13/2014US20140336174 Glucosylceramide Synthase Inhibition For The Treatment Of Collapsing Glomerulopathy And Other Glomerular Disease
11/13/2014US20140336172 Novel 2H-Indazoles as EP2 Receptor Antagonists
11/13/2014US20140336168 Nampt inhibitors
11/13/2014US20140336143 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
11/13/2014US20140336137 Novel nitroso compounds as nitroxyl donors and methods of use thereof
11/13/2014US20140336120 Compositions And Method For Treatment Of Ischemic Neuronal Reperfusion Injury
11/13/2014US20140335177 Pharmaceutical composition
11/11/2014US8884034 TOFA analogs useful in treating dermatological disorders or conditions
11/11/2014US8883962 Zinc-responsive peptides, and methods of use thereof
11/11/2014US8883843 Substituted isoindoline-1,3-dione derivatives
11/11/2014US8883818 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
11/11/2014US8883810 Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
11/11/2014US8883798 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof
11/11/2014US8883793 Tubulin inhibitors and methods of using the same
11/11/2014US8883792 Substituted isoquinoline derivative
11/11/2014US8883789 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 694